RXST R&D to Revenue
28.67%Fiscal year
Period ending:
RXST FY R&D/Revenue%
1474.84%-130.83%
2019-12-312025-12-31
Source: Financial Modeling Prep (FMP). Annual fiscal periods. Dates are period ends; a fiscal year may differ from a calendar year.
RXST r&d to revenue history
R&D spending as percentage of revenue. The available annual fiscal periods series contains 7 observations from Dec 31, 2019 to Dec 31, 2025.
| Period ending | R&D to Revenue |
|---|---|
| 28.6659% | |
| 24.5607% | |
| 32.6134% | |
| 53.017% | |
| 108.4362% | |
| 149.4345% | |
| 1,319.4556% |
Compare r&d to revenue
All RXST financial metrics · RXST stock overview · How to interpret financial metrics
